Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Investigation, Laboratory test, Physical examination
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 010M20A and 025L0A) for COVID-19 vaccination.     The patient's past medical history included Pain in hip (both left and right), Rotator cuff tear (right), Exposure to unspecified agent (observation and evaluation), Joint pain (bilateral right greater than left), Fall, Disturbance of skin sensation, Foot pain (right lateral), Vertigo and Hormone replacement therapy. Previously administered products included for Prophylaxis: Influenza vaccine (1st dose) on 19-Sep-2019, Influenza vaccine (2nd dose) on 14-Sep-2020 and Influenza vaccine (3rd dose) on 25-Oct-2021. Past adverse reactions to the above products included No adverse event with Influenza vaccine, Influenza vaccine and Influenza vaccine. Family history included Kidney cancer (Kidney cancer to brother). Concurrent medical conditions included Drug allergy (moderate), Drug allergy (moderate), Iron deficiency, Thoracic aortic aneurysm (4 cm by 3.8 cm), Postmenopausal syndrome, Breast nodule (right, 7 Clock position), Fibrocystic breast disease, Chronic rhinitis, Hyperlipidemia and Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), FISH OIL, LINUM USITATISSIMUM SEED OIL (FLAX SEED OIL), ESTRADIOL, NORETHISTERONE ACETATE (COMBIPATCH), VITAMIN D3 and PRAVASTATIN SODIUM for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Investigation: not reported (Inconclusive) Not reported, not reported (Inconclusive) Not reported, not reported (Inconclusive) Not reported, not reported (Inconclusive) Not reported, not reported (Inconclusive) Not reported, not reported (Inconclusive) Not reported and not reported (Inconclusive) Not reported. On an unknown date, Laboratory test: not reported (Inconclusive) Not reported. On an unknown date, Physical examination: not reported (Inconclusive) Not reported.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was on long term antihyperlipidemic use.  On 9th November 2021, the vial was initially stored in the refrigerator.  The vial did not undergo any temperature excursions.  No treatment medication were provided.  The patient was due for her Flu, Pneumovax and TD booster vaccines.  The reporter wanted to know if the 2069 expiration date on the packing slip was a valid expiration date.